Company Filing History:
Years Active: 2017
Title: Koyo Shudo: Innovator in Antitumor Research
Introduction
Koyo Shudo is a prominent inventor based in Hanno, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development of antitumor agents. With a total of 2 patents, Shudo's work focuses on enhancing the efficacy of existing cancer therapies.
Latest Patents
Shudo's latest patents include an antitumor effect potentiator and an antitumor agent. The first patent provides a formulation that enhances the antitumor activity of tegafur, which is administered in a therapeutically effective amount. It also includes gimeracil, which is effective for enhancing the antitumor effect, and oteracil potassium, which helps inhibit side effects. Additionally, the formulation comprises folinic acid and its pharmacologically acceptable salts. The patent outlines methods for enhancing the antitumor effect of the agent and inhibiting tumor growth through the administration of this potentiator.
Career Highlights
Koyo Shudo is associated with Taiho Pharmaceutical Company Limited, where he continues to advance his research in oncology. His work has been instrumental in developing new therapeutic strategies for cancer treatment, showcasing his commitment to improving patient outcomes.
Collaborations
Shudo collaborates with Junji Uchida, a fellow researcher, to further explore innovative solutions in cancer therapy. Their partnership exemplifies the collaborative spirit in the scientific community, aimed at tackling complex health challenges.
Conclusion
Koyo Shudo's contributions to antitumor research highlight his dedication to enhancing cancer treatment methodologies. His innovative patents and collaborations reflect a significant impact on the field of oncology.